日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

3,3'-Diindolylmethane Improves the Viral Pneumonia Outcomes After Influenza and SARS-CoV-2 Infection in Animal Models

3,3'-二吲哚甲烷可改善动物模型中流感和SARS-CoV-2感染后的病毒性肺炎预后

Kiselev, Vsevolod; Leneva, Irina; Ivanina, Anna; Poromov, Artem; Falynskova, Irina; Kartashova, Nadezhda; Glubokova, Ekaterina; Trunova, Galina; Sudakov, Sergey; Drukh, Vadim; Zverev, Vitaly; Kiselev, Oleg

First results of the double-blind randomized placebo-controlled multicenter clinical trial of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN)

一项旨在通过个性化方法逆转前列腺上皮内瘤变 (PIN) 的基于 DIM 的疗法的双盲随机安慰剂对照多中心临床试验的初步结果

Paltsev, Mikhail; Kiselev, Vsevolod; Drukh, Vadim; Muyzhnek, Ekaterina; Kuznetsov, Igor; Andrianova, Evgeniya; Baranovskiy, Pavel

Double-blind randomized placebo-controlled multicenter clinical trial (phase IIa) on diindolylmethane's efficacy and safety in the treatment of CIN: implications for cervical cancer prevention

一项关于二吲哚甲烷治疗宫颈上皮内瘤变(CIN)的疗效和安全性的双盲、随机、安慰剂对照、多中心临床试验(IIa期):对宫颈癌预防的意义

Ashrafian, Levon; Sukhikh, Gennady; Kiselev, Vsevolod; Paltsev, Mikhail; Drukh, Vadim; Kuznetsov, Igor; Muyzhnek, Ekaterina; Apolikhina, Inna; Andrianova, Evgeniya

Safety and tolerability of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN)

以DIM为基础的疗法作为逆转前列腺上皮内瘤变(PIN)的个性化方法的安全性和耐受性

Paltsev, Mikhail; Kiselev, Vsevolod; Muyzhnek, Ekaterina; Drukh, Vadim; Kuznetsov, Igor; Pchelintseva, Olga

Comparative preclinical pharmacokinetics study of 3,3'-diindolylmethane formulations: is personalized treatment and targeted chemoprevention in the horizon?

3,3'-二吲哚甲烷制剂的临床前药代动力学比较研究:个性化治疗和靶向化学预防是否指日可待?

Paltsev, Mikhail; Kiselev, Vsevolod; Muyzhnek, Ekaterina; Drukh, Vadim; Kuznetsov, Igor; Pchelintseva, Olga